United Therapeutics Corporation (UTHR): Price and Financial Metrics

United Therapeutics Corporation (UTHR): $305.35

1.43 (+0.47%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

B

Add UTHR to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#21 of 301

in industry

UTHR Price/Volume Stats

Current price $305.35 52-week high $417.82
Prev. close $303.92 52-week low $264.33
Day low $300.46 Volume 518,000
Day high $305.74 Avg. volume 460,772
50-day MA $301.58 Dividend yield N/A
200-day MA $343.02 Market Cap 13.77B

UTHR Stock Price Chart Interactive Chart >


United Therapeutics Corporation (UTHR) Company Bio


United Therapeutics develops and commercializes products to address the unmet medical needs of patients with chronic and life-threatening conditions worldwide. Its lead product comprises Remodulin, an injection used for the treatment of pulmonary arterial hypertension. The company was founded in 1996 and is based in Silver Spring, Maryland.


UTHR Latest News Stream


Event/Time News Detail
Loading, please wait...

UTHR Latest Social Stream


Loading social stream, please wait...

View Full UTHR Social Stream

UTHR Price Returns

1-mo 7.24%
3-mo -17.60%
6-mo -14.99%
1-year 11.34%
3-year 64.72%
5-year 156.04%
YTD -13.46%
2024 60.46%
2023 -20.93%
2022 28.70%
2021 42.35%
2020 72.33%

Continue Researching UTHR

Want to see what other sources are saying about UNITED THERAPEUTICS Corp's financials and stock price? Try the links below:

UNITED THERAPEUTICS Corp (UTHR) Stock Price | Nasdaq
UNITED THERAPEUTICS Corp (UTHR) Stock Quote, History and News - Yahoo Finance
UNITED THERAPEUTICS Corp (UTHR) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!